(Cys8)-pTH (1-8) (human) is a peptide fragment of parathyroid hormone (PTH) with a cysteine substitution at position 8, providing the ability to form disulfide bonds and stabilize the peptide. This modification enhances the fragment's ability to interact with PTH receptors. Researchers use it to explore the structure-activity relationships and receptor-binding dynamics of PTH, focusing on bone metabolism and calcium regulation.
CAT No: P03050
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.